XENE earnings: a positive outcome, +12.3%

On May 10, 2022, Xenon Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.3% in the window around the event. It had already run -21.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.